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Abstract
The importance of Zn for optimal functioning of the immune system and antioxidant stress
response is well documented. Zn homeostasis influences development and function of immune
cells, activity of stress-related and antioxidant proteins [metallothioneins (MT), chaperones, ApoJ,
Poly(ADP-Ribose) polymerase-1 (PARP-1) and Methionione Sulfoxide Reductase (Msr),
Superoxide Dismutase (SOD)], and helps to maintain genomic integrity and stability. During ageing,
the intake of Zn decreases due to inadequate diet and/or intestinal malabsorption, contributing to
frailty, general disability and increased incidence of age-related degenerative diseases (cancer,
infections and atherosclerosis). Although many factors contributing to Zn deficiency have been
identified, the biochemical markers of Zn deficiency as well as the possibility to achieve relevant
health benefits through Zn supplementation in the elderly are still a matter for evaluation. Taking
into account that Zn homeostasis is regulated by proteins and enzymes for which polymorphisms
have been previously found to be associated with successful/unsuccessful ageing, genetic screening
might be of added value in evaluating the individual response to Zn supplementation. Biochemical,
immunological, dietary and genetic studies aimed at understanding the impact of Zn in healthy
ageing, the effect of Zn supplementation in the elderly and finally formulating a rationale for the
promotion of correct Zn supplementation were discussed at the international Zincage conference
held in Ancona in January 2007.
Introduction
Zincage [1] is a specific targeted research project (STREP)
funded by the European Union in the 6th Framework Pro-
gram (FP6). It includes epidemiological studies on the
influence of diet and lifestyle on healthy ageing, aimed at
preventing adult degenerative disease, particularly focus-
ing on cardiovascular diseases and also addressing malnu-
trition of the elderly. The conference held in Ancona,
January 2007, was focussed particularly on the effects of
Zn supplementation in the elderly and on the possible
influences of dietary, biochemical and genetic factors on
the individual response. Zn deficiency, cell-mediated
immune dysfunction and increased oxidative stress are
common in elderly subjects and it is quite clear that die-
tary habits including Zn consumption have a great impact
on these factors. Zn supplementation in the elderly can
improve the immune response and reduce oxidative stress
markers, thereby contributing to a reduced incidence of
infections. However, individual differences in the
response to Zn can lead to contradictory results even with
supplementation trials performed in elderly people of the
same age-groups. One of the reasons for these individual
differences is the different genetic background of the sub-
jects enrolled in the study. In fact, some proteins with doc-
umented polymorphic sites are involved in regulating Zn
homeostasis. One important class of such proteins are the
metallothioneins (MT), which bind Zn with high affinity
but, at the same time, release free Zn ions in response to
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oxidative/nitrosative stress and thereby modulate the
expression of Zn-dependent genes and activate antioxi-
dant enzymes. Differences in Zn status have also been
observed in individuals carrying different alleles for poly-
morphisms of pro-inflammatory cytokines (i.e. IL-6 and
TNF-alpha). In addition, the individual response can be
modulated by dietary habits because Zn absorption and
availability is dependent on the intake of other nutrients
and trace elements.
These aspects have been poorly studied because the intra-
cellular mechanisms involved in the regulation of Zn
homeostasis are not well understood in the context of
aging. Moreover, even if it is known that Zn can modulate
antioxidant responses, very little, if any, focused research
aimed at identifying the targets of the intracellular
response in ageing has been undertaken. What is known
is that during ageing, the intake of Zn decreases, thus con-
tributing to frailty, general disability and increased inci-
dence of age-related degenerative diseases (cancer,
infections and atherosclerosis). This situation may be
worsened or ameliorated in different European countries,
due to the large differences in extrinsic (dietary habits and
socio-economic conditions) and intrinsic factors (genetic
background) affecting Zn homeostasis in southern and
northern European countries. One of the aims of the Zin-
cage project was to investigate how these factors affect the
response to Zn, and thus to contribute to better evaluation
of the need for this supplement in elderly populations.
Zn, genetic background and longevity
Recent advances in understanding molecular and biologi-
cal processes, evolutionary biology, and epidemiological
data strongly suggest that human longevity is the product
of genetic, environmental and stochastic interactions.
What has been identified as an unfavourable genetic back-
ground for the risk of age-related disease and for longevity
in some geographic areas is often not confirmed by stud-
ies performed in different regions. This suggests that envi-
ronmental factors strongly interact with the individual
genetic background. Different studies on European die-
tary habits confirm that the intake of micronutrients,
including Zn, is different among different European coun-
tries. Moreover, the products of some genes with docu-
mented polymorphic sites are involved in regulating Zn
homeostasis and inflammatory response, thereby affect-
ing the propensity to develop Zn deficiency at advanced
age. This means that in order to perform appropriate Zn
supplementation in the elderly, it is necessary to take into
account the Zn status, dietary habits and the individual
genetic background of each person [2]. This last point may
be crucial also in order to identify subjects that are at
higher risk to develop Zn deficiency in aging. Here, then,
there is potential for a preventive intervention with Zn
supplementation as suggested by Eugenio Mocchegiani
(INRCA-Italian National Research Centres on Aging,
Italy), who reported variability in the response to Zn sup-
plementation according to IL-6-174 and MT1A +647 pol-
ymorphisms as well as to country of origin. Zn
supplementation (48 ± 2 days) at a dose of 10 mg/day as
Zn aspartate (Unizink 50, Kohler Pharma GmbH, Ger-
many) induced a general increase of Zn levels in the
whole supplemented sample (n = 148 elderly), but sub-
jects harbouring different genotypes showed different
responses both in the increases of plasma Zn and the
intracellular Zn status. This finding becomes of para-
mount importance when we consider the well known role
of Zn homeostasis in regulating inflammatory responses
[3]. In fact, according to the antagonistic pleiotropy the-
ory of ageing, natural selection has favoured genes confer-
ring short-term benefits to the organism at the cost of
deterioration in later life. Inflamm-aging, the low-grade,
chronic, systemic inflammatory state that characterizes
the aging process, is just an example of the antagonistic
theory as explained by Claudio Franceschi (University of
Bologna, Italy). Franceschi reviewed recent advances in
understanding the unusual genetics of human longevity,
pointing out that a major contribution derives from pro-
inflammatory and anti-inflammatory genes generally
associated with age-related diseases [4]. Accordingly, Cal-
ogero Caruso (University of Palermo, Italy) reviewed
the reports indicating an association between the risk of
Alzheimer Disease (AD) and polymorphisms of genes
encoding inflammatory mediators, such as IL-1β, IL-6, IL-
10 and TNF-α [5], as well as the possible involvement of
Zn. In this respect, the presence of Zn dyshomeostasis in
the AD brain could be related to the dysregulation of
inflammatory mediators in AD patients. However, clear
evidence for a possible interplay between dietary Zn and
risk of AD is still missing.
Zn and brain
In neurodegenerative diseases, especially AD, a growing
literature suggests pathogenic links between Zn and path-
ways involved in neurodegeneration. While Zn supple-
mentation has beneficial antinflammatory effects, it can
also play a pivotal role in the polymerization of Aβ pep-
tide, and plaque formation. Therefore, when supplemen-
tating the elderly with Zn, one should always keep in
mind that excessive Zn might have very serious deleteri-
ous effects. To address the neurotoxic role of Zn in neuro-
logical diseases, Stefano Sensi (University G.
D'Annunzio, Italy) showed how an excessive increase in
intracellular free Zn++, either by influx through glutamate
ionotropic receptor-associated channels or the mobiliza-
tion of the cation from MTs and mitochondria, can act as
a potent catalytic factor in exacerbating neuronal death in
response to excitotoxic levels of glutamate [6]. The excito-
toxic cascade by which Zn exerts its neurotoxicity includes
mitochondrial and extra-mitochondrial production ofImmunity & Ageing 2007, 4:5 http://www.immunityageing.com/content/4/1/5
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reactive oxygen species and disruption of metabolic enzy-
matic activity, ultimately leading to neuronal necrosis
and/or apoptosis. Therefore, not only deficit but also
excess of zinc is a condition that may be detrimental, espe-
cially for neuronal cells, which are particularly sensitive to
oxidative stress. However, the precise role of zinc in AD
and other neurodegenerative diseases is difficult to define
because these diseases are progressive, apparently irrevers-
ible and fatal, so that it is very difficult to discriminate
causal or contributing factors from compensatory defen-
sive mechanisms. Paolo Zatta and Denise Drago (Uni-
versity of Padova, Italy) showed the aggregation kinetic
of amyloid-beta after exposure to trace elements (Al, Zn,
Fe and Cu) [7]. The most dramatic effects were observed
with Al3+, and to a lesser extent with Zn, which in turn
induced the formation of unstructured filaments which
were less toxic than the ones induced by Al3+. Ageing is
also associated with a progressive decrease of mitochon-
drial metabolic competence with the appearance of a kind
of mosaicism characterized by increased mitochondria
with metabolic impairments or complete metabolic defi-
ciency [8]. Carlo Bertoni (INRCA-Italian National
Research Centres on Aging, Italy) illustrated this phe-
nomenon in association with the age-related changes in
the synaptic structural dynamics with a particular focus on
the mitochondrial targets of Zn. These targets include
complexes of the mitochondrial electron transport chain,
components of the tricarboxylic acid cycle, and enzymes
of glycolysis. An inhibitory effect of Zn on these targets is
most likely, but the relevance of this phenomenon in age-
ing remains to be investigated appropriately.
Zn and oxidative stress
A number of Zn-dependent stress-related proteins (PARP-
1, ApoJ, MT, NO, chaperones) and the activity of Zn-
dependent (SOD) and other (GPX and catalase) antioxi-
dant enzymes in the elderly, as well as the role of the pro-
teasomal system in the degradation of proteins whose
abnormal accumulation is harmful in ageing, as well as
the role of methionine sulfoxide reductase (Msr) in repair-
ing oxidised proteins were all investigated during the Zin-
cage Project. Alexander Buerkle and Andrea Kunzmann
(University of Konstanz, Germany) showed that cellular
poly(ADP-ribosyl)ation is positively correlated with Zn
status in human peripheral blood mononuclear cells
(PBMC), and confirmed that an age-related decrease of
PARP-1 occurs with "in vitro" (T Cell Clone model) and
"in vivo" ageing [9]. Zn supplementation "in vitro"
increased Poly(ADP-ribosyl)ation in T-cell clones (TCC)
and similar effects were obtained after "in vivo" supple-
mentation in elderly people. The influence of Zn on
PARP-1 activity could impact on cellular capacity to repair
DNA strand breaks. María Moreno-Villanueva (Univer-
sity of Konstanz, Germany) investigated the effect of ex-
vivo Zn supplementation on DNA strand break repair,
demonstrating that Zn has a highly significant, positive
effect on DNA repair if baseline repair is low (perhaps due
to Zn deficiency). The influence of Zn on reactive oxygen
species (ROS) production in PBMC from healthy elderly
subjects, before and after Zn supplementation, was inves-
tigated by Jolanta Jajte (Medical University of Lodz,
Poland). She found that Zn may play an important role in
lowering oxidative stress in cells of elderly subjects [10],
although this effect was not uniform and depended on
age, gender and Zn status before supplementation. Efs-
tathios S. Gonos and Ioannis P. Trougakos (NHRF –
The National Hellenic Research Foundation, Greece)
showed that also the Clusterin/Apolipoprotein J (ApoJ)
gene is responsive to Zn [11]. MT and ApoJ are both
involved in cell differentiation, so these results may sug-
gest that the Zn released by MT could affect cell differenti-
ation by affecting ApoJ expression. A positive correlation
between ApoJ and Zn was also shown in the plasma of
healthy old subjects and an increasing trend was observed
post-supplementation. The origin of the differences in the
modulation of ApoJ following supplementation are still
being evaluated. The fact that MT can be involved in the
regulation of ApoJ as well as other Zn-dependent stress-
related proteins make it very relevant to understand the
changes occurring in the function of these proteins with
advancing age. Marco Malavolta (INRCA-Italian
National Research Centres on Aging, Italy) illustrated
the age related changes of these proteins and the interplay
between MT protein and mRNA expression as well as their
respective modulation by Zn ions and pro-inflammatory
cytokines [12]. MT were found to be associated with age-
ing, cognitive impairment and perceived stress only when
there was reduced NO-induced release of Zn, in other
words, in the presence of oxidized and perhaps dysfunc-
tional MT. Therefore, the increased MT observed follow-
ing Zn supplementation as well as in the presence of good
Zn status, seems a positive sign generally associated with
optimal NO-induced release of Zn and fully functional
MT. The hypothesis of dysfunctional MT in ageing was in
part confirmed by the results on glutathionylated MT
found by Marco Colasanti (University of Rome 3, Italy)
[13]. The involvement of these proteins in age-related dis-
ease as well as their contribution to longevity, was also
confirmed by association studies on MT polymorphisms
[14], longevity and cardiovascular disease carried out by
Robertina Giacconi and Elisa Muti (INRCA-Italian
National Research Centres on Aging, Italy). Other tar-
gets of the antioxidant Zn response are likely to be
methionine sulfoxide reductase (Msr) and the proteas-
ome system. Bertrand Friguet and Isabelle Petropoulos
(Université Paris 7 Denis-Diderot, France) showed that
ageing is associated with a decrease of proteasome chymo-
trypsin-like peptidase and Msr activities, implicating an
impaired response to accumulation of oxidative damage
with ageing [15]. In this regard, very relevant results wereImmunity & Ageing 2007, 4:5 http://www.immunityageing.com/content/4/1/5
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obtained by Zn supplementation in elderly, as shown by
Filipe Cabreiro (Université Paris 7 Denis-Diderot,
France) in that Zn supplementation improved both pro-
teasome chymotrypsin-like peptidase and Msr activities in
the elderly, thus restoring at least in part the intracellular
defences against oxidative damage in PBMC [16]. This
phenomenon is also evident for chaperone inducibility
which, in turn, is markedly reduced in PBMC from old
donors [17]. Csaba Sõti and Ákos Putics (Semmelweis
University, Hungary) demonstrated that Zn supplemen-
tation in elderly subjects induced a marked, significant
increase in Hsp72 inducibility upon heat stress. Further-
more, Hsp72 induction displayed a strong correlation
with Zn bioavailability, suggesting that Zn is a co-inducer
of the stress response and a possibly important modulator
of the adaptability of the immune system in the elderly.
The impact of Zn supplementation on plasma antioxidant
enzymes of elderly subjects [18] was studied by Patrizia
Mecocci (University of Perugia, Italy). An increased
activity of plasma superoxide dismutase and erythrocyte
superoxide dismutase, and decreased activity of plasma
Cat and GPx were found after supplementation. The rea-
son for such "compensatory" antioxidant enzyme levels is
an intriguing clue, perhaps dependent on several factors
including genetic background, that will be the object of
further investigations. Finally, Wolfgang Maret (Univer-
sity of Texas Medical Branch, TX, USA) reviewed the
redox biology of Zn and MT, focusing on the control of
oxidative signalling by the latter [19]. These signals, esti-
mated in picomolar amounts of Zn, appear to be potent
effectors. Amplitudes of Zn signals are determined by the
cellular Zn buffering capacity, which is in turn regulated
by MT. Therefore, the possible age-associated loss of the
ability to make Zn available for insertion into newly syn-
thesized Zn metalloenzymes could be related to the age-
related changes in MT and oxidative stress.
Zn and genomic stability
Some Zn-dependent enzymes involved in the stress
response, such as Poly(ADP-ribose) polymerase (PARP-
1), are concerned with the maintenance of telomere func-
tion and genomic stability. A fast and reliable high-
throughput quantitative method to measure telomere
length has been developed by Maria Blasco and Andres
Canela (CNIO – Centro Nacional de Investigaciones
Oncológicas, Spain), by adapting standard Q-FISH to a
96-well format, coupled with automated microscopy [20].
Applying this method, a significant increment of mean
telomere length after Zn supplementation was observed
in German donors, whereas Italians displayed no changes.
These results confirm that inherited and environmental
factors may contribute to affect the response to Zn supple-
mentation. In this respect, specific experiments have been
performed by Dawn Mazzatti and Jonathan Powell
(Unilever Research Colworth, UK) by applying nutrige-
nomic and nutrigenetic approaches to explore the effects
of Zn on gene expression profiles [21] of young and eld-
erly people and to correlate the response in PBMC from
elderly subjects to IL-6-174 and MT +647 polymorphisms.
At least 13 genes were found to be commonly regulated by
Zn in elderly and young donors (independently of age),
whereas most of the other genes were differentially regu-
lated. A very relevant point was the differential regulation
of primarily metabolic pathways in the young compared
to a mainly inflammatory response in the elderly. How-
ever, a subset of the elderly population with MT1A +647
and IL-6-174 polymorphisms (C+C- carriers) responded
very favourably to Zn treatment by reduction in inflam-
matory cytokine production and altered regulation of
energy metabolism. Because these individuals are at high
risk for age-related diseases, the anti-inflammatory effects
of Zn may represent an important intervention to restore
immune function and reduce risk of morbidity and mor-
tality. Jolanta Jajte and Janusz Blasiak (Medical Univer-
sity of Lodz, Poland) studied the impact of Zn
supplementation on DNA damage and DNA repair in Zn-
supplemented elderly subjects using single cell gel electro-
phoresis assays (Comet assay) [22]. The overall results
suggested that Zn supplementation may favour the
response of the cells to DNA damage, especially in women
above 70 years (an age class with a particularly high risk
of Zn deficiency) and that DNA repair processes can be
also stimulated by Zn.
Zn and signal triggering
It is well known that Zn is involved in the mechanisms of
cell cycling, proliferation, cell death and signal transduc-
tion, but the modulation of these processes following "in
vivo" Zn supplementation in elderly subjects is still an
open question. Georges Herbein, Tamas Fulop and
Audrey Varin (Université de Franche – Comté, France)
investigated IL-6 and IL-2 signalling [23], focusing on the
activation of the STAT pathway in T cells of elderly healthy
subjects supplemented with Zn. They showed that when
subjects with marginal Zn deficiency were treated with
physiological doses of Zn, no changes in Jak/STAT signal-
ling under IL-2 and IL-6 stimulation occur, suggesting that
Zn deficiency was not the underlying cause of the signal-
ling defect and correlating well with previous results on in
vitro Zn supplementation. The presence of large differ-
ences due to a different basal Zn status, country of origin,
gender and genetic background, could partially explain
the lack of a clear homogeneous response. Conversely, Zn
supplementation seemed to have a quite homogeneous
effect regarding the modulation of apoptotic mecha-
nisms.  Daniela Monti and Rita Ostan (University of
Florence, Italy) studied the effect of Zn supplementation
on mitochondrial membrane depolarization during spon-
taneous and deoxyribose-induced apoptosis [24]. Their
results indicated a clear protective effect of Zn both inImmunity & Ageing 2007, 4:5 http://www.immunityageing.com/content/4/1/5
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spontaneous and induced apoptosis. However, when the
possible protective effect of Zn was evaluated in relation
with polymorphism (codon 72) of the Zn-dependent fac-
tor p53, no difference was observed between Pro-and
Pro+ carriers, suggesting that the possible protective effect
of Zn on apoptosis is independent of the p53 polymor-
phism. No effect was observed in cell cycling before and
after Zn supplementation except for a slight reduction of
G2/M phase after Zn supplementation. Further experi-
ments and clinical trials are necessary to clarify the effect
of Zn supplementation in vivo because these encouraging
preliminary suggest that this approach could be useful in
studying all those diseases with a pathogenesis related to
oxidative stress. In particular the involvement of Zn trans-
porters remains scarcely studied. Nevertheless, it is known
that the involvement of Zn in the mechanisms of apopto-
sis and cell cycling is not only due to its release from MT
but also from the regulation of its influx/efflux via Zn
transporters. Israel Sekler (Ben-Gurion University of the
Negev, Israel) described the molecular mechanisms of Zn
homeostasis, with a particular focus on the molecular
identity, function and regulation of Zn transporters [25].
He presented a new hypothesis and results on the regula-
tion of vesicular Zn transporters and Na+/Zn++ membrane
exchange mechanisms which will surely be the object of
future research in this field.
Zn and immune mediators
Long term clonal cultures represent good models for stud-
ying the behaviour of T cells under chronic antigenic stress
and facilitate the in vitro testing of interventions in a lon-
gitudinal ageing system. This reflects the situation in eld-
erly individuals in which T cells are required to maintain
immunity to persistent pathogens, particularly herpes
viruses (and especially CMV and EBV), throughout life
[26]. These virus-specific T cell clones are sequentially lost
during ageing. Longitudinal studies of free-living very eld-
erly people have suggested that such clonal attrition pre-
dicts mortality. Jürgen Kempf and Graham Pawelec
(University of Tubingen, Germany) showed an increased
ability of T cell clones cultured long-term in certain con-
centrations of Zn to synthesise chaperone proteins, fol-
lowing sublethal heat shock. This protective effect of Zn
was even more marked when the cells were challenged
with a second, higher, otherwise lethal, heat shock. Thus,
if these phenomena also occur in vivo, Zn supplementa-
tion may facilitate protective hormetic events in chroni-
cally stressed T cells and help to prevent the clonal
attrition characteristic of the terminal stage of life.
The role of the thymus is vital for orchestration of T cell
development and maturation. Richard Aspinall and
Wayne Mitchell (Imperial College London, UK) evalu-
ated the role played by Zn in maintaining thymic output
in healthy supplemented elderly individuals [27]. Analys-
ing subjects from different countries, no significant differ-
ence was observed in levels of detectable T cell receptor
excision circles (TREC) after Zn supplementation with
respect to basal levels. This was found to be the case for
both males and females. However, an increasing trend for
individuals with particularly low TREC measurements
was observed in some countries i.e. males from Italy,
Poland and Greece, suggesting that factors affecting indi-
vidual differences could play a major role. The influence
of genetic factors on the immune system was investigated
by Erminia Mariani (Istituti Ortopedici Rizzoli, Italy)
through the assessment of NK activity and the levels of a
pool of pro-inflammatory cytokines and chemokines in
elderly subjects [28] before and after Zn supplementation.
She reported a general increase of NK cell cytotoxicity after
Zn supplementation independent of the country of origin
but with differences related to IL-6-174 and MT1A +647
polymorphisms. Regarding the inflammatory profile, it
was found to be generally decreased in Italian and Ger-
man supplemented elderly, whereas it was increased in
Greek and Polish subjects. Other than the country of ori-
gin, many differences were found when considering indi-
vidual chemokine and cytokine levels in relation to
genetic background, basal Zn status and more general die-
tary habits. These results confirm that Zn is a key trace ele-
ment for a prompt immune response to external noxae.
On the other hand, Lothar Rink (RWTH Aachen Univer-
sity, Germany) reported that Zn inhibited basal pro-
inflammatory cytokine production but stimulated pro-
duction after antigen stimulation [29]. He also reported a
series of beneficial effects of Zn supplementation
observed in the supplemented elderly including reconsti-
tuted TH1-cytokine release, decreased spontaneous
cytokine production and decreased numbers of activated
T cells. All these results were most likely attributed to the
increase of intracellular labile Zn in the PBMC of elderly
subjects following the supplementation period. Intracel-
lular labile Zn could represent an important marker with
possible use in clinical diagnosis of Zn deficiency. The
involvement of Zn transporters in modulating intracellu-
lar labile zinc during ageing was also discussed. Finally, a
comprehensive review of the essentiality of Zn for
humans was provided by Ananda Prasad (Wayne State
University School of Medicine, USA). He described how
Zn deficiency affects immune function and illustrated that
what can be called a "Zn deficiency syndrome", affects
about two billion people [30]. Thus, correction of Zn defi-
ciency is likely to have a great impact on the health of a
large population in the developing world and this could
be applicable to the elderly population.
Zn, nutrition and health
Maternal/fetal nutrition is an important factor in the ori-
gin of certain common diseases that affect adults and
cause morbidity among the elderly. Contributions of spe-Immunity & Ageing 2007, 4:5 http://www.immunityageing.com/content/4/1/5
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cific micronutrient deficiencies to the phenomenon can
be inferred. Because Zn deficiency affects at least 1 in 5
people worldwide, and Zn is essential for many functions
[31], not the least of which is the structure/function of
thousands of proteins, evidence of the critical importance
of Zn for human pregnancy, and effects of Zn deficiency
during early development in rats on brain maturation and
subsequent function in later life was discussed by Harold
Sandstead (University of Texas Medical Branch, USA).
The essentiality of Zn for nucleic acid and protein synthe-
sis, and certain epigenetic processes, might explain these
experimental findings. Zinc nutriture's specific effects of
on epigenetic processes are incompletely understood.
Here is the problem of how and how much ageing affects
Zn homeostasis and requirements. Sue J Fairweather-Tait
(Institute of Food Research, Norwick, UK) reviewed this
aspect showing that the responses to Zn loading measured
as changes in plasma Zn, urinary Zn excretion and liver Zn
increase with age while the fraction of Zn taken up by red
blood cells decreased with age. Additionally she illus-
trated how Zn absorption is affected by the intake of other
nutrients or trace elements [32]. Therefore, a complete
evaluation of dietary habits could help to understand the
propensity towards Zn deficiency. The Mediterranean diet
has been suggested as a strong modulator of the health
status and a determinant of longevity. The assessment of
adherence to the Mediterranean diet in European old pop-
ulations and the investigation of its impact on inflamma-
tory and Zn status was addressed by George Dedoussis
(Harokopio University, Greece). He showed that in
Greece, where the greatest incidence of obesity among eld-
erly was found [33], as well as in Poland, there is a lower
adherence to the Mediterranean diet sometimes associ-
ated with a lower Zn intake than in the rest of Europe. This
issue was further reported in detail for the Italian popula-
tion by Cinzia Giuli and Roberta Papa (INRCA-Italian
National Research Centres on Aging, Italy). The rela-
tionship between "Zn status" and psycho-social condi-
tions, especially in countries with the highest propensity
towards age-related Zn deficiency [34], was illustrated by
Fiorella Marcellini (INRCA-Italian National Research
Centres on Aging, Italy). She observed also a slight but
beneficial effect of Zn supplementation on cognitive func-
tions of elderly subjects supplemented with Zn. Taking
into account that most of these elderly subjects carried
specific alleles for IL-6-174 and MT1A +647 polymor-
phisms, these results further confirm that the response to
Zn intake/supplementation can be affected by the genetic
background of each individual.
Conclusion
Zn research in the context of ageing is still in a relatively
early stage. Several improvements in sensitivity and spe-
cificity of methods to assess Zn status have been devel-
oped, but severe limitations in reproducibility still exist.
Nevertheless, new knowledge on the function of metal-
lothioneins and Zn transporters in ageing has been
acquired. Recent results obtained with Zn supplementa-
tion in elderly subjects are encouraging. Many factors were
found to affect the individual response to Zn, such as gen-
eral dietary habits, genotype, gender, drug usage and
frailty. This makes it very difficult to draw a definitive con-
clusion regarding the possible benefits of Zn supplemen-
tation during ageing. However, some progress in
understanding how Zn can modulate oxidative stress
responses and host defence to infection has been achieved
and will hopefully be the subject of further scientific
enquiry. It is also clear that in order to clarify many aspects
related to the health benefits of Zn, a longitudinal
approach will be helpful using cohorts of subjects whose
past dietary habits and clinical data can be easily accessed.
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